Prior to joining ENDRA as chief technology officer in 2007, Michael Thornton was a founder and president of Enhanced Vision Systems Corp., or EVS, a developer and supplier of medical imaging equipment to the pharmaceutical, biotech and academic sectors.
In 2002, EVS was acquired by General Electric Company. Following the acquisition of EVS by GE, Thornton held a number of positions at GE Healthcare, including sales manager, global product manager and site leader. He was a member of the leadership team that expanded the pre-clinical imaging business to include: computed tomography, optical and positron emission tomography imaging technologies, with global market reach. He is also a founder of Volumetrics Medical Corp., a developer and manufacturer of quality assurance devices for diagnostic imaging.
Prior to founding EVS, Thornton developed medical imaging related technologies at the Robarts Research Institute (London, Ontario, Canada) for which he obtained a master’s in electrical engineering from the University of Western Ontario. Thornton also holds a bachelor’s in electrical engineering from the University of Toronto and is a member of the American Association of Physicists in Medicine.
What is Michael Milos Thornton's net worth?
The estimated net worth of Michael Milos Thornton is at least $93.86 as of May 18th, 2023. Mr. Thornton owns 19 shares of ENDRA Life Sciences stock worth more than $94 as of April 10th. This net worth estimate does not reflect any other assets that Mr. Thornton may own. Learn More about Michael Milos Thornton's net worth.
How do I contact Michael Milos Thornton?
Has Michael Milos Thornton been buying or selling shares of ENDRA Life Sciences?
Michael Milos Thornton has not been actively trading shares of ENDRA Life Sciences during the last ninety days. Most recently, on Thursday, May 18th, Michael Milos Thornton bought 8 shares of ENDRA Life Sciences stock. The stock was acquired at an average cost of $2,887.50 per share, with a total value of $23,100.00. Following the completion of the transaction, the chief technology officer now directly owns 19 shares of the company's stock, valued at $54,862.50. Learn More on Michael Milos Thornton's trading history.
Who are ENDRA Life Sciences' active insiders?
